Global Custom Market Research Reports Provider Company


TRACON Pharmaceuticals Inc (TCON) - Financial and Strategic SWOT Analysis Review

  • Published Date: 13 Nov 2017
  • Number of Pages: 25
  • Category: Healthcare and Medical
  • Country: United States of America

TRACON Pharmaceuticals Inc (TRACON) is a biopharmaceutical company that develops and commercializes targeted therapies for cancer, age-related macular degeneration and fibrotic diseases. The company offers pipeline products such as TRC105, TRC102, TRC253, TRC694, and TRC205. Its lead product TRC105, is an anti-endoglin antibody that is being developed for the treatment of multiple solid tumor types in combination with VEGF inhibitors. Its TRC102, is a small molecule that is in clinical development for the treatment of lung cancer and glioblastoma. TRACON conducts pre-clinical studies for various products. The company works in collaboration with universities and institutions. TRACON is headquartered in San Diego, California, the US.

TRACON Pharmaceuticals Inc Key Recent Developments

Nov 07,2017: TRACON Pharmaceuticals Reports Third Quarter Financial Results and Provides Corporate Update
Aug 08,2017: TRACON Pharmaceuticals Reports Second Quarter Financial Results and Provides Corporate Update
May 10,2017: TRACON Pharmaceuticals Reports First Quarter Financial Results and Provides Corporate Update
Apr 10,2017: TRACON receives Most Innovative Clinical Trial Design award for Phase III angiosarcoma trial
Feb 28,2017: TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2016 Financial Results and Provides Corporate Update

This comprehensive SWOT profile of TRACON Pharmaceuticals Inc provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalDatas Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, GlobalDatas highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of TRACON Pharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description A detailed description of the companys operations and business divisions.

- Corporate strategy Analysts summarization of the companys business strategy.

- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.

- Company history Progression of key events associated with the company.

- Major products and services A list of major products, services and brands of the company.

- Key competitors A list of key competitors to the company.

- Key employees A list of the key executives of the company.

- Executive biographies A brief Summary of the executives employment history.

- Key operational heads A list of personnel heading key departments/functions.

- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Publisher Name : GlobalData
Table of Contents

Section 1 - About the Company

TRACON Pharmaceuticals Inc - Key Information

TRACON Pharmaceuticals Inc - Overview

TRACON Pharmaceuticals Inc - Key Employees

TRACON Pharmaceuticals Inc - Key Employee Biographies

TRACON Pharmaceuticals Inc - Key Operational Heads

TRACON Pharmaceuticals Inc - Major Products and Services

TRACON Pharmaceuticals Inc - History

TRACON Pharmaceuticals Inc - Company Statement

TRACON Pharmaceuticals Inc - Locations And Subsidiaries

TRACON Pharmaceuticals Inc - Key Manufacturing facilities

Head Office

Other Locations & Subsidiaries

Section 2 - Company Analysis

TRACON Pharmaceuticals Inc - Business Description

TRACON Pharmaceuticals Inc - Corporate Strategy

TRACON Pharmaceuticals Inc - SWOT Analysis

SWOT Analysis - Overview

TRACON Pharmaceuticals Inc - Strengths

TRACON Pharmaceuticals Inc - Weaknesses

TRACON Pharmaceuticals Inc - Opportunities

TRACON Pharmaceuticals Inc - Threats

TRACON Pharmaceuticals Inc - Key Competitors

Section 3 - Company Financial Performance Charts

TRACON Pharmaceuticals Inc - Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 - Appendix



Ratio Definitions

About GlobalData

Contact Us


Note*: Some sections may be missing if data is unavailable for the company

List Of Tables

TRACON Pharmaceuticals Inc, Key Information

TRACON Pharmaceuticals Inc, Key Ratios

TRACON Pharmaceuticals Inc, Share Data

TRACON Pharmaceuticals Inc, Major Products and Services

TRACON Pharmaceuticals Inc, History

TRACON Pharmaceuticals Inc, Key Employees

TRACON Pharmaceuticals Inc, Key Employee Biographies

TRACON Pharmaceuticals Inc, Key Operational Heads

TRACON Pharmaceuticals Inc, Other Locations

TRACON Pharmaceuticals Inc, Subsidiaries

TRACON Pharmaceuticals Inc, Key Manufacturing facilities

TRACON Pharmaceuticals Inc, Key Competitors

TRACON Pharmaceuticals Inc, SWOT Analysis

TRACON Pharmaceuticals Inc, Ratios based on current share price

TRACON Pharmaceuticals Inc, Annual Ratios

TRACON Pharmaceuticals Inc, Interim Ratios

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List Of Figures

TRACON Pharmaceuticals Inc, Performance Chart

TRACON Pharmaceuticals Inc, Ratio Charts

TRACON Pharmaceuticals Inc (TRACON) is a biopharmaceutical company that develops and commercializes targeted therapies for cancer, age-related macular degeneration and fibrotic diseases. The company offers pipeline products such as TRC105,

View Report

This report studies Itraconazole Powder in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from

View Report

In this report, the Asia-Pacific Itraconazole Powder market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports